BridgeMD
New treatment option for Cancer
Official title Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
ClinicalTrials.gov ID: NCT07073807
What this study is testing
- What it's testing
- New oral anticancer treatments have improved survival across cancer types but introduced challenges in medication adherence and symptom management. The SMART pilot trial will test a new mobile health intervention that facilitates remote adherence and symptom monitoring, patient-provider communication outside of clinic visits regarding the use of oral anticancer treatments, and support for financial and social needs, as well as health literacy support, for 30 English- and Spanish-speaking patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Must speak English or Spanish
- Must be 18 years of age or older
- Have a diagnosis of any type and stage of cancer
- Have a new prescription for an oral anticancer therapy (OAT) initiated within the last 90 days or planned to start within the next 15 days
- Be receiving treatment at UCI Chao Family Comprehensive Cancer Center-affiliated oncology clinics
You likely can't join if
- Have an Eastern Cooperative Oncology Group (ECOG) performance status greater than 2
- Be medically or cognitively unable to give consent or participate in the study
- Be participating in another clinical trial that monitors adherence or symptoms related to the newly prescribed OAT
See the full eligibility criteria
- Must speak English or Spanish
- Must be 18 years of age or older
- Have a diagnosis of any type and stage of cancer
- Have a new prescription for an oral anticancer therapy (OAT) initiated within the last 90 days or planned to start within the next 15 days
- Be receiving treatment at UCI Chao Family Comprehensive Cancer Center-affiliated oncology clinics
- Own a smartphone and be willing to receive study-related text messages.
- Have an Eastern Cooperative Oncology Group (ECOG) performance status greater than 2
- Be medically or cognitively unable to give consent or participate in the study
- Be participating in another clinical trial that monitors adherence or symptoms related to the newly prescribed OAT
The study team makes the final eligibility decision.
Where it's taking place
- Irvine, California, United States
- Newport Beach, California, United States
- Orange, California, United States
- Yorba Linda, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Irvine, California, United States; Newport Beach, California, United States; Orange, California, United States; Yorba Linda, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.